SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-021078
Filing Date
2024-02-27
Accepted
2024-02-27 16:02:04
Documents
108
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cere-20231231.htm   iXBRL 10-K 3774031
2 EX-10.12 cere-ex10_12.htm EX-10.12 62063
3 EX-10.32 cere-ex10_32.htm EX-10.32 37703
4 EX-10.33 cere-ex10_33.htm EX-10.33 67540
5 EX-10.34 cere-ex10_34.htm EX-10.34 23174
6 EX-23.1 cere-ex23_1.htm EX-23.1 9883
7 EX-31.1 cere-ex31_1.htm EX-31.1 13922
8 EX-31.2 cere-ex31_2.htm EX-31.2 14047
9 EX-32.1 cere-ex32_1.htm EX-32.1 7821
10 EX-32.2 cere-ex32_2.htm EX-32.2 8324
11 EX-97.1 cere-ex97_1.htm EX-97.1 42497
12 GRAPHIC img33056374_0.jpg GRAPHIC 1818729
13 GRAPHIC img33056374_1.jpg GRAPHIC 1395208
  Complete submission text file 0000950170-24-021078.txt   22789526

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cere-20231231.xsd EX-101.SCH 2031865
110 EXTRACTED XBRL INSTANCE DOCUMENT cere-20231231_htm.xml XML 2825543
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39311 | Film No.: 24686358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)